[Clinico-hemodynamic effects of psychotropic preparations and psychosomatic correlations in cardiac rhythm disorders]. 1986

T R Petrova, and V V Skibitskiĭ

A total of 136 patients with paroxysmal supraventricular tachyarrhythmia and tachyform of atrial fibrillation and polytopic extrasystoles were examined. The combination of cardiovascular and psychovegetative disturbances closely related to the expression of psychopathological shifts was revealed. The antiarrhythmic activity of psychotropic drugs (phenibut, sulpiride, pipofezin, tofizopam and falilepsin) depending on the nature of the time course of the emotional-personality status in prolonged intermittent treatment of patients with arrhythmias of the functional and mixed genesis was shown. A negative inotropic effect of phenibut, a hyperdynamic effect of sulpiride, pipofezin, falilepsin and a modulating effect of tofizopam were revealed. Prolonged therapy with psychopharmacological drugs in short courses was proposed.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008950 MMPI A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes. Minnesota Multiphasic Personality Inventory
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009449 Neurocirculatory Asthenia A clinical syndrome characterized by palpitation, SHORTNESS OF BREATH, labored breathing, subjective complaints of effort and discomfort, all following slight PHYSICAL EXERTION. Other symptoms may be DIZZINESS, tremulousness, SWEATING, and INSOMNIA. Neurocirculatory asthenia is most typically seen as a form of anxiety disorder. Cardiac Neurosis,Effort Syndrome,Hyperkinetic Heart Syndrome,Phobia, Cardiac,Asthenia, Neurocirculatory,Cardiac Neuroses,Cardiac Phobia,Heart Syndrome, Hyperkinetic,Neurocirculatory Asthenias,Neurosis, Cardiac,Syndrome, Effort,Syndrome, Hyperkinetic Heart
D010551 Personality Behavior-response patterns that characterize the individual. Personalities
D011602 Psychophysiologic Disorders A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988) Psychosomatic Disorders,Psychophysiological Disorders,Psychophysiologic Disorder,Psychophysiological Disorder,Psychosomatic Disorder
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005117 Cardiac Complexes, Premature A group of cardiac arrhythmias in which the cardiac contractions are not initiated at the SINOATRIAL NODE. They include both atrial and ventricular premature beats, and are also known as extra or ectopic heartbeats. Their frequency is increased in heart diseases. Ectopic Heartbeats,Extrasystole,Premature Beats,Premature Cardiac Complexes,Cardiac Complex, Premature,Extrasystoles,Premature Cardiac Complex,Beat, Premature,Beats, Premature,Complexes, Premature Cardiac,Ectopic Heartbeat,Heartbeat, Ectopic,Heartbeats, Ectopic,Premature Beat,Premature Cardiac Complices
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

T R Petrova, and V V Skibitskiĭ
April 1958, Archives des maladies du coeur et des vaisseaux,
T R Petrova, and V V Skibitskiĭ
February 1979, Psychosomatics,
T R Petrova, and V V Skibitskiĭ
September 1978, Kardiologiia,
T R Petrova, and V V Skibitskiĭ
December 1979, Psychosomatics,
T R Petrova, and V V Skibitskiĭ
April 1961, La Semana medica,
T R Petrova, and V V Skibitskiĭ
January 2013, Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine,
T R Petrova, and V V Skibitskiĭ
September 1966, The Journal of pediatrics,
T R Petrova, and V V Skibitskiĭ
January 1978, Revue medicale de Liege,
Copied contents to your clipboard!